Head-to-head · computed 2026-08-11
Henry Meds vs Hims & Hers
Henry Meds: Henry's all-inclusive semaglutide runs $297/month ($247 on 6-month and $197 on 12-month prepaid bundles) and tirzepatide $349/month; a separately marketed 'as low as $149' microdose floor is a different program. Hims & Hers: After settling with Novo Nordisk on March 9, 2026 and exiting compounded semaglutide for new patients, Hims & Hers now runs a branded-only GLP-1 service: Wegovy injection $299/month, oral Wegovy $249/month, and Zepbound $399/month, on top of a $149/month membership ($39 first month) plus $5 shipping.
Tirzepatide
| Henry Meds | Hims & Hers | |
|---|---|---|
| All-in maintenance | $179/mo | $548/mo |
| Best plan rate | $179/mo | $548/mo |
| 12-month total | $2,148 | $6,576 |
| Status | Reported · 2026-07-14 | Reported · 2026-08-11 |
The arithmetic
On the figures our desk holds, Henry Meds's $179 a month undercuts Hims & Hers's $548 by $369 a month at the 10 mg/wk maintenance basis — $4,428 across a year. Henry Meds's figure is reported (captured 2026-07-14) and Hims & Hers's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Henry Meds's tirzepatide ladder runs $179 a month billed monthly. Hims & Hers's runs $548 a month billed monthly. On the twelve-month basis Henry Meds's $2,148 beats Hims & Hers's $6,576 by $4,428 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Semaglutide
| Henry Meds | Hims & Hers | |
|---|---|---|
| All-in maintenance | $179/mo | $453/mo |
| Best plan rate | $197/mo | $453/mo |
| 12-month total | $2,364 | $5,436 |
| Status | Provider-stated · 2026-08-05 | Reported · 2026-08-11 |
The arithmetic
On the figures our desk holds, Henry Meds's $297 a month undercuts Hims & Hers's $453 by $156 a month at the 2.4 mg/wk maintenance basis — $1,872 across a year. Henry Meds's figure is provider-stated (captured 2026-08-05) and Hims & Hers's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Henry Meds's semaglutide ladder runs $297 a month billed monthly, $247 a month on a six-month plan, and $197 a month on a twelve-month plan. Hims & Hers's runs $453 a month billed monthly. On the twelve-month basis Henry Meds's $2,364 beats Hims & Hers's $5,436 by $3,072 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.
Where the structures genuinely differ
Henry Meds carries no membership fee against Hims & Hers's $149 a month — $1,788 a year of structural cost before any medication ships, which is why this site prices everything all-in. On dose economics, Henry Meds is dose-flat — the price survives titration — while Hims & Hers's pricing can move with the dose, a difference that compounds through a standard escalation schedule and matters most to buyers expecting to reach the higher maintenance doses. On exit terms, Hims & Hers's structure avoids prepaid lock-in while Henry Meds's better rates ride prepaid terms — cheaper per month, costlier to leave early; read the refund language before choosing the discount.
Structure, side by side
Henry Meds
- MembershipNone
- Dose policyFlat — $179/mo tirzepatide and $179/mo semaglutide at every dose, per reported sources
- CommitmentMonth-to-month; 6/12-month bundles prepaid
- CancellationCancel before renewal; bundle refunds limited
- PharmacyPartner pharmacies
Hims & Hers
- Membership$149/mo
- Dose policyBrand list pricing by product
- CommitmentMembership month-to-month ($39 first month)
- CancellationCancel anytime
- PharmacyBrand fulfillment (Wegovy, oral Wegovy, Zepbound) + partner pharmacy
What our desk is watching on each
Henry Meds: Two independent 2026 captures (RangeYourself Jul 2026, RxPepsDirect May 2026) consistently show $179/mo flat for tirzepatide, replacing our Aug-5 $349 provider-stated figure. Henry's pharmacy partner is not publicly named. Semaglutide plan tiers ($179–$297) remain from our prior captures pending full reconciliation with the updated tirz figure.
Hims & Hers: The membership is the number that moves the math: a $299 Wegovy pen becomes ~$453/month all-in. Compare against going to NovoCare or LillyDirect directly.
Questions people ask
Is Henry Meds or Hims & Hers cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does Henry Meds vs Hims & Hers miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do Henry Meds and Hims & Hers cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $2,148 at Henry Meds and $6,576 at Hims & Hers — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Henry Meds · Hims & Hers. Official sites: Henry Meds ↗ · Hims & Hers ↗. Nothing here is medical advice.